5AM Ventures
Overview
5AM Ventures is a venture capital firm focused on funding and building next-generation life science companies. They support companies that are working to solve important healthcare needs via cutting-edge breakthroughs in medicine and science. The firm invests in early-stage venture capital investments in life science companies and also makes follow-on investments in life science companies, as well as later-stage private and/or publicly held companies in life science-related fields .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Mendra, Inc. | Jan 2026 | Series A | Lead |
| Mendra, Inc. | Jan 2026 | Series A | Lead |
| Kinaset Therapeutics | Jan 2026 | Series B | Co-investor |
| ProLynx Inc. | Dec 2025 | Series A | Lead |
| Ensoma | Sep 2025 | Financing | Co-investor |
Key People
Scott Rocklage
Founding Partner
Andy Schwab
Managing Partner
John Diekman
Founding and Managing Partner
Kush Parmar
Managing Partner
Arthur Tzianabos
Venture Partner
Elliott Levy
Venture Partner
Paula Soteropoulos
Venture Partner
Steve Hitchcock
Venture Partner
Anna Cosslett Yaeger
Partner, Head Of Public Equities
Michael Calore
Partner, Head Of Investor Relations
Stone Paul A.
Partner, Chief Legal Officer, Chief Compliance Officer
John Kelly
Partner, Chief Financial Officer, Chief Operating Officer
Katie Bodner Spielberg
Principal
Max Farina
Principal
Britt Inga Emerson
Investor Relations Manager
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
